Hyponatraemia in patients on immune checkpoint inhibitors
Open Access
- 14 November 2022
- journal article
- letter
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 13
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guidelineEuropean Journal of Endocrinology, 2022
- Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall SurvivalFrontiers in Oncology, 2022
- Adrenal insufficiencyThe Lancet, 2021
- How we treat endocrine complications of immune checkpoint inhibitorsESMO Open, 2021
- Endocrine Toxicity of Cancer Immunotherapy Targeting Immune CheckpointsEndocrine Reviews, 2018
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor RegimensJAMA Oncology, 2018
- Endocrine sequelae of immune checkpoint inhibitorsHormones, 2017
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012